Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Byotrol's share price for the quarter that ended in Sep. 2023 was €0.008. Byotrol's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 456.17 Mil. Therefore, Byotrol's market cap for the quarter that ended in Sep. 2023 was €3.65 Mil.
Byotrol's quarterly market cap
declined
from Sep. 2022 (€9.53 Mil) to Mar. 2023 (€4.09 Mil) and
declined
from Mar. 2023 (€4.09 Mil) to Sep. 2023 (€3.65 Mil).
Byotrol's annual market cap
declined
from Mar. 2021 (€28.13 Mil) to Mar. 2022 (€13.39 Mil) and
declined
from Mar. 2022 (€13.39 Mil) to Mar. 2023 (€4.09 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Byotrol's Enterprise Value for Today is €0.77 Mil.
Byotrol Market Cap Historical Data
The historical data trend for Byotrol's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Byotrol's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Byotrol's Market Cap Distribution in the Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Byotrol's Market Cap distribution charts can be found below:
* The bar in red indicates where Byotrol's Market Cap falls into.
Byotrol Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Byotrol's Market Cap for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Byotrol (FRA:B7Y) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Byotrol Market Cap Related Terms
Thank you for viewing the detailed overview of Byotrol's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Byotrol PLC is a developer of consumer and professional antimicrobial technologies and products. It is engaged in the development, patenting, licensing, and sale of anti-microbial products and technologies for business and consumer use. It operates in two reportable segments, being Professional (including Human Health, Animal Health, Facilities Management, and Food & Beverage), and Consumer (Including Household, Skin Care, and Pet Care). Its customers are based in the UK, North America, Asia, and the Rest of the World. The company generates key revenue from product sales - sale of anti-microbial technology and includes Royalty and licensing income.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:B7Y has been successfully added to your 